Register for our free email digests:
Latest From Organon Teknika Corp.
In its latest attempt to get out in front of drug shortage problems, FDA’s announcement that Sanofi Pasteur’s bladder cancer drug TheraCys is unavailable due to manufacturing problems also notifies patients that Merck is stepping into the breach.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- 4SC AG
- Senior Management
Jason Loveridge, PhD, CEO
Frank Hermann, MD, Chief Dev. Officer
Roland Baumgartner, PhD, CSO
Susanne Danhauser-Riedl, MD, CMO
- Contact Info
Phone: (49) 89 700763 0
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.